Speaker

Kemp Dolliver

Director of Research, Brookline Capital Markets

Conferences: 1
Keynotes: 0
Upcoming: 1

Oncology & Cancer Research
Pharmacy & Pharmaceutical Sciences

Upcoming appearances

8th Targeted Radiopharmaceuticals Summit Europe 2026
1–3 Dec 2026London, United Kingdom
- PanelInvestor Strategy Panel: From Specialist Therapy to Standard of Care: What Must Happen for RLTs to Become a Commercially Scalable Oncology Modality?

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Kemp Dolliver, and it lists only the talks, sessions and presentations named in those programmes.